Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PLNT | CBU |
|---|---|---|
| Price | $42.07 | $60.13 |
| Change today | ▼ 0.80% | ▼ 0.92% |
| Market cap | $3.16B | $3.16B |
| Return, 3 months | -19.6% | -9.4% |
| Return, year to date | -61.2% | +7.1% |
| Return, 1 year | -57.1% | +5.1% |
| P/E (TTM) | 14.3 | 14.0 |
| P/B | -5.2 | 1.5 |
| P/E percentile vs own 5y | 0th | 2nd |
| Dividend yield | – | 3.13% |
| Revenue growth (YoY, latest qtr) | – | +12.2% |
| Net profit growth (YoY) | – | +19.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 27.4% |
| Return on equity | – | – |
| Analyst target vs. price | +62.7% | +15.9% |
| Analyst buy share | 79% | 0% |
| RSI (14) | 35 | 39 |
| 30-day volatility | 46.1% | 14.3% |
| Max drawdown, 1 year | -63.8% | -16.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
